CT
Capricor Therapeutics Inc
🇺🇸XNAS.CAPRUnited StatesHealthcare
$8.56USDdown -0.01 (-0.12%)ClosedDelayed1:50 AM
Price$8.56-0.01 (-0.12%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US14070B3096
- CUSIP
- 14070B309
Company
- Employees
- 231
- Headquarters
- San Diego, United States
- Website
- https://www.capricor.com
- CEO
- Dr. Linda Marbán Ph.D.
Market
- Shares outstanding
- 58.1M
- Market cap
- $497.67M
Key dates
- Next earnings
- Nov 9, 2026
Highlights
- Market cap
- $497.67M
- EPS LTM
- -$2.23
- P/E LTM
- -3.83calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $0-100%down year on year
- Net income
- -$129.42M-84.94%down year on year
- Gross margin
- Not reported
- Free cash flow
- -$129.78M-130.19%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.